Microbe interactions, immune response applications, and epidemiology

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/74

encourage image

There's no tags or description

Looks like no tags are added yet.

75 Terms

1
New cards

immunocompromised

having a weakness or defect in the innate or adaptive defenses

2
New cards

physical barriers against invading microorganisms

skin and mucous membranes

3
New cards

symbiosis

living together of two dissimilar organisms or symbionts

4
New cards

microbiome

the community of microorganisms, as well as their geetic information, in a given environment

5
New cards

primary pathogen

amicrobe able to cause in an otherwise healthy individual

6
New cards

oppotunistic pathogen

a microbe that causes disease only when introducedinto an unusual location or into an immunocompromised host

7
New cards

virulence

the degree of pathogenicity

8
New cards

colonization

establishmentand growth of a microorganissm on a surface

9
New cards

infection

colonization by a pathogen on or within the body, used if there is a parasitic relationship betwen the microbe and the ost

10
New cards

disease

a condition that prevent the body from functioning normally

11
New cards

symptoms

subjetive efects of disease experienced by the patient like paina and nausea

12
New cards

signs

objective evidence of disease such as rash, pus formation, and sweling (things you can see)

13
New cards

primary pathogen

can cause disease even in an healthy individual

14
New cards

opportunistic pathogen

causes disease only when the body'ds defenses are weakened

15
New cards

virulence factors

traits of a microoranism that specifically allow it to cause disease (the genes for these traits can sometimes be transferred horizontally)

16
New cards

infectious dose

number of microbes necessary to establish an infection

17
New cards

bacteremia

presence of bacterial cells circulating in the blood

18
New cards

toxemia

indicated that toxins are ciculating in the bloodstream

19
New cards

viremia

indicates that viral particles are circulating in the bloodstream

20
New cards

adhesin molecules

a component of microorganisms that bacteria use to atach to host cells that are located most commonly on the tips of pili, the fimbriae, and other surface structures

21
New cards

receptor

where the adhesin attaches and each has distinct roles for the host (typically are glycoproteins, glycolipids)

22
New cards

factors causing individuals to be immunocompromised

genetic defects, malnutrition, infancy, elderly, stress, immunosuppressive drugs, and someinfections

23
New cards

primary pathogen

causes disease in a healthy host with intact immune defenses

24
New cards

how do pathogens overcome barriers to colonization

motility through the fflagella is used to penetrate mucus layers, produce enymes (mucinase or IgA protease) to break down mucus and secretory antibodies, competing with normal microbiota for nutrients and binding sites

25
New cards

What happens when effetor proteins are injected into human cells through a Type III secretion system?

They are like a syringe and reprgram the host cell to be able to do phagocytosis by rearranging their cytoskeleton and engulf the bacteria, this dirupts cell signaling trigeringcell apoptosis

26
New cards

pathogenic mechanisms to penetrate the skin

entry through wounds, burns, insect/animal bites, medical devicesor any other opening

27
New cards

pathogenic mechanisms to penetrate mucus membranes

passing pathogens through the M cells in mucosal tissue as they are specialized sampling cells, inducing endocytoss through epithelial cells, or moving between cells by breaking down tight junctions

28
New cards

How do bacteria avoid innate host and adaptive defenses

  • hiding within host cells

  • avoiding complement/phhagocytosis

  • surviving inside phagocytes

  • avoiding antibodies


29
New cards

why is damaging host cells good for bacteria?

releases nutrients from dead cells, allows deeper spread into tissues, eliminates competing host immune cells, and triggers symptoms that facilitate transmission to new hosts

30
New cards

exotoxins

proteins secreted by gram + and - bacteria, that are heat lalibble, have a very high potency,causes specific damage, and can form toxoids

31
New cards

endotoxins

lipid portion of LPS in the outer membrane of gram - bacteria only that are released from apoptosis, is heat stable with lower potency, triggers general systeic inflammation

32
New cards

strategies viruses use to outsmart innate and adaptive defenses

  • antigenic variation

  • blocking MHC 1 presentations

  • inhibiting interferon/apoptosis


33
New cards

antigenic variation

mutating surface spikes rabpily so existing antibodies no longer recognize them

34
New cards

blocking MHC 1 presentation

preventing infected cells from displaying ciral antigens to Tc cells

35
New cards

inhibiting interferon/apoptosis

prducing proteins that block host interferon signaling or prevent the infected cells from self-destructing before viral replication finishes

36
New cards

naturally acquired active immunity

exposure to a live pathogen through natural infection, host makes own antibodies and memory cells

37
New cards

artifically active immunity

vaccination with weakend/dead pathogen or anitgen, hos tmakesown antibodies and memory cells (long lasting)

38
New cards

naturally acquired passive immunity

antibodies passed from mother to baby via placenta (IgG) or breast milk, IgA, immediate protection, no memory (temporary)

39
New cards

artifically acquired passive immunity

injection of pre-formed anitbodies/antiserum, immediate protection, no memory (temporary)

40
New cards

attenuated vaccines

live-weakened, replicates in host,strong long lasting cell-mediated and humoral immunity, usually 1 dose

rise of reverion to virulence, unsafe for immunocompromised/pregnant individuals, requires strict refrigeration

41
New cards

inactivated vaccines

killed/subunit, cannot replicate or cause disease, very safe and stable

weaker immune eresponse since mostly humoral, requires boosters and adjuvants

42
New cards

nucleic acid vaccines

fast to manufacture and design, triggers strong humoral and Tc cell responses without a live pathogen

requires ultra cold storage (especially with mRNA), causes temporary inflammatory side eeffects

43
New cards

Whole-agent inactivted

entire microbe killed via heat or chemicals

44
New cards

subunit inactivated vaccines

only purified antigenic pieces of the microbe

45
New cards

toxoid inactivated

inactivated bacterial toxins that still stimulate antitoxin antibodies

46
New cards

conjugate inactivated vaccines

bacterial polysaccharides linked to a carrier protein to help infants mount a T-dependent response

47
New cards

how does an mRNA vaccine create artificial immunity

  • lipid nanoparticles deliver spike mRNA into human muscle/dendritic cells

  • host ribosomes translate the mRNA directly in the cytoplasm into viral spike proteins without transcription

  • innate receptors sense the mRNA/lipids and triggers local inflammaitons

  • host cells display spike fragment on MHC 1 and MHC 11 molecules

  • helper T cells activate B cells, producing neutralizing anti-spike antibodies, and Tc cells, leaving behind long-lived memory B and T cells


48
New cards

how are known antibodies used to find unknown antigens

directly detects itself, or its proteins, in a patient sample

49
New cards

how are known antigens used to detect unknown antibody?

detects whether the patient's immune sytem has produced antibodies against a specific pathogen

50
New cards

direct immunoasay test

using a single enzyme-labeled primary antibody that binds dirretly to the target antigen

51
New cards

indirect immunoassy test

detects patient antibodies using a known antigen immobilized on a plate, followed by an unlabeled patient anitbody,and finally a labeled anti-human secondary antibody

52
New cards

COVID-19 PCR test

targets viral RNA from a nasal/saliva swab, that is slow in speed, it has the highest sensitivity or specificity, and diagnoses an active infection

53
New cards

COVID-19 antigen test

targets viral surface proteins through a nasal swab, it is fast, has moderate sensitivity, and diagnoses active infection

54
New cards

COVID-19 antibody test

targets the patients IgM/IgG antibodies in the blood serum, is fast to moderate in speed, is very reliable for ast exposure but not for early infection, is used to determine prior infection or vaccination

55
New cards

Aggulation tests

immunoassays where multivalent antibodies cross link particulate antigens into visible clumps. used for blood typing and rapid pathogen identification

56
New cards

Influenza symptems and pathogenesis

causitive agent: influennzavirus

sudden high fever, chills, severe myalgia, headahe, fatigue, dry cough, and sore throat

HA binds respiratory epithelial cells, viral replication kills ciliated epithelial cells, stripping the mucociliary escalator and prediposing the host to secondary bacterial pneumonia

57
New cards

influenza epide., treatment, and prevention

spreads through respiratory droplets and aerosols, peaks seasonally in winter, birds and pigs serves as major reservoirs

neuraminidase inhibitors or cap-dependent endonuclease inhibitos taken within 48 hours of symptom onset

annual quadrivalent/trivalent flu vaccines and respiratory hygiene

58
New cards

antigenic drift

minor, gradual point mutation in HA and NA genes, causes seasonal epidemics because existing antibodies only partially recognize the altered spikes

59
New cards

antigenic shift

major, abrupt reassortment of segmented RNA genomes when two different flu strains infect the same host cell. creates a novel virus subtype causing global pandemics

60
New cards

how do vaccines provide herd immunity

when a high percenage of a pop. is imunizzed, transmission chains are broken because the pathogen runs out of susceptible hosts, indirectly protecting vulnerable individuals who cannot be vaccinated

61
New cards

why are rates recorded rather than raw number of infected individuals

rates account for total pop. size and a specific time frame, which allows for fair comparison between cities or countries of vastly different sizes

62
New cards

incidence

number of new cases during a specific time period

63
New cards

prevalance

total number of existing cases at a given time

64
New cards

morbidity

rate of illness/disease in a population

65
New cards

mortality

rate of death cause by a disease in a population

66
New cards

case fatality-rate

the percentage of individuals diagnossed with a speciic disease who die from that disease within a givven time frame

(deaths confirmed/confirmed cases)*100

67
New cards

spradic

occurs occasionally and irreegularly in isolated cases

68
New cards

endemic

constantly present at a predictable, baseline level in a specific geographic area

69
New cards

outbreak

a sudden, localized spike in casees above the expected baseline

70
New cards

epidemic

a widespread, rapid increase in cases above normal expectation across a larger region or country

71
New cards

pandemic

an epidemic that spreads across multiple continents or worldwide

72
New cards

chain of infection

infectious agent —> reservoir -→ portal of exi —> mode of transmission —> portal of entry -→ susceptible host

73
New cards

infectious dose nfluence disease epi

low —- allows rapid person to person spread from tiny exposures

74
New cards

incubation period influence disease epi

long ---- allow infected people to unknowigly transmit the pathogen for nomonths/years before symptoms appear

75
New cards

host pop. influence disease epi

high pop- density, low vaccination rates, malnutirtion, or large elderly/immunocompromised groups accelerate outbreaks